Volume | 549,513 |
|
|||||
News | - | ||||||
Day High | 21.795 | Low High |
|||||
Day Low | 20.95 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.66 | 20.95 | 21.795 | 21.11 | 21.57 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,830 | 549,513 | $ 21.32 | $ 11,718,034 | - | 12.3202 - 32.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:33 | 10 | $ 21.0999 | USD |
Cassava Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.3M | 43.23M | - | 0 | -97.22M | -2.25 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cassava Sciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 22.20 | 23.725 | 19.93 | 21.82 | 1,084,167 | -1.10 | -4.95% |
1 Month | 24.61 | 26.6757 | 19.435 | 21.83 | 1,081,874 | -3.51 | -14.26% |
3 Months | 24.50 | 26.6757 | 18.18 | 21.67 | 823,438 | -3.40 | -13.88% |
6 Months | 22.27 | 32.10 | 18.18 | 23.64 | 923,810 | -1.17 | -5.25% |
1 Year | 23.15 | 32.10 | 12.3202 | 21.71 | 995,270 | -2.05 | -8.86% |
3 Years | 41.44 | 146.16 | 12.3202 | 49.53 | 2,370,947 | -20.34 | -49.08% |
5 Years | 1.07 | 146.16 | 1.00 | 34.18 | 2,790,240 | 20.03 | 1,871.96% |
Cassava Sciences Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |